Published in Cancer on August 01, 1988
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia. Haematologica (2011) 1.25
Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome). Am J Pathol (2002) 1.00
Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia. Clin Mol Pathol (1996) 0.75
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med (1990) 3.21
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med (1996) 2.52
Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry (1992) 2.15
Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine. N Engl J Med (1992) 2.15
Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene (1997) 1.97
Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood (1998) 1.73
The Finnish evidence-based guideline for open-angle glaucoma. Acta Ophthalmol Scand (2003) 1.66
Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia. Lancet (1985) 1.46
Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia. Br J Haematol (1994) 1.41
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Br J Haematol (1996) 1.40
Bone marrow transplantation in Europe: major geographical differences. The European Group for Bone Marrow Transplantation [EBMT]. J Intern Med (1993) 1.39
Inversion of chromosome 14 marks human T-cell chronic lymphocytic leukaemia. Nature (1984) 1.39
[Randomization and ethics. Patient participation is a serious demand in medical research]. Lakartidningen (1992) 1.38
Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis. Exp Cell Res (1970) 1.37
Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis (1986) 1.28
Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis (1985) 1.25
Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections. Blood (1992) 1.21
A predictive model for the clinical response to low dose ara-C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia. Br J Haematol (1992) 1.16
Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc Natl Acad Sci U S A (1990) 1.15
B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. Clin Exp Immunol (1978) 1.14
Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation (1984) 1.08
Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. Blood (1985) 1.08
Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation. Blood (1984) 1.06
Trisomy 8 in acute myeloblastic leukemia and sideroachrestic anemia. Blood (1974) 1.06
Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res (1997) 1.03
Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting. Gene Ther (2001) 1.03
Graft-versus-myeloma effect. Lancet (1996) 1.02
In-vitro antibacterial activity of SQ 26,776. J Antimicrob Chemother (1981) 1.01
Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection. Br J Haematol (1986) 1.01
Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer (1976) 1.00
6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood (1998) 1.00
Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis (1989) 0.98
Foscarnet for cytomegalovirus infections. Lancet (1985) 0.98
Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation. Blood (1980) 0.97
13q deletions in lymphoid malignancies. Blood (1995) 0.97
Mechanisms behind hypocholesterolaemia in hairy cell leukaemia. BMJ (1995) 0.96
Acute leukemia in professional drivers exposed to gasoline and diesel. Eur J Haematol (1991) 0.95
Albuterol via Turbuhaler versus albuterol via pressurized metered-dose inhaler in asthma. Ann Allergy Asthma Immunol (1997) 0.94
Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res (1989) 0.94
Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications. Cancer Genet Cytogenet (1990) 0.93
Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients. Cancer Res (1980) 0.92
Interferon-alpha treatment of a patient with acute lymphoblastic leukaemia and Down's syndrome. Effects on natural killer cell activity and mitogen responsiveness. Scand J Haematol (1984) 0.92
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplant (1996) 0.92
Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. Bone Marrow Transplant (1986) 0.91
Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14. Genomics (2000) 0.90
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant (2001) 0.90
Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction. Eur Respir J (1997) 0.90
Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis (1990) 0.90
Suicide gene therapy for plasma cell tumors. Blood (1996) 0.90
Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood (1983) 0.90
Mitogen-induced switching of immunoglobulin heavy-chain class secretion in chronic B-lymphocytic leukaemia and immunocytoma cell populations. Scand J Immunol (1983) 0.89
Antibody-dependent cellular cytotoxicity of leukaemic blast cells and neutrophils from patients with acute myelogenous leukaemia. Clin Exp Immunol (1982) 0.89
Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. Proc Natl Acad Sci U S A (1993) 0.89
Successful treatment of pure red-cell aplasia with cyclosporin. Lancet (1984) 0.89
Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study. J Clin Oncol (2004) 0.89
Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing. Br J Haematol (1993) 0.89
Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X. N Engl J Med (1987) 0.88
Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy. Bone Marrow Transplant (1991) 0.88
Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin. N Engl J Med (1983) 0.88
Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia. Cancer (1974) 0.88
Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. J Infect Dis (1984) 0.87
Differential expression of mRNAs for neuropeptide Y-related peptides in rat nervous tissues: possible evolutionary conservation. J Neurosci (1992) 0.87
Retinoblastoma gene deletions in B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer (1992) 0.87
A new variant translocation (19q plus, 22q minus) in chronic myelocytic leukemia. Exp Cell Res (1974) 0.86
Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood (1994) 0.86
Selective decontamination of alimentary tract microbial flora in patients treated with bone marrow transplantation. A microbiological study. Scand J Infect Dis (1984) 0.86
Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma. Cancer Gene Ther (2006) 0.86
Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood (1995) 0.86
Increased risk of developing acute leukemia after employment as a painter. Cancer (1987) 0.85
Cytogenetics in CLL and related disorders. Baillieres Clin Haematol (1993) 0.84
Clinical impact of chromosomal aberrations in multiple myeloma. J Intern Med (2010) 0.84
Ox erythrocyte cytotoxicity by phorbol myristate acetate-activated human neutrophils. Scand J Immunol (1983) 0.84
Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma. Respir Med (1998) 0.84
Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients--a one-year follow-up. Transplantation (1985) 0.84
Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden. Ann Oncol (1994) 0.84
Clinical findings and prognostic factors in chronic myeloid leukemias. Acta Med Scand (1986) 0.84
Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group. Bone Marrow Transplant (1996) 0.84
Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates. Genomics (1999) 0.84
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant (1993) 0.84
Stimulation of human myelopoiesis by leukotriene B4. Biochem Biophys Res Commun (1985) 0.83
Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia. Proc Natl Acad Sci U S A (1990) 0.83
Pharmacokinetics of daunorubicin and doxorubicin in plasma and leukemic cells from patients with acute nonlymphoblastic leukemia. Ther Drug Monit (1989) 0.83
A quantitative cytochemical investigations of DNA, RNA and protein in lymphoid cells from normal, preleukemic and leukemic mice. Exp Cell Res (1966) 0.83
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1997) 0.83
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2013) 0.82
Concentration of angiotensin-converting enzyme in tears of patients with sarcoidosis. Acta Ophthalmol (Copenh) (1987) 0.82
High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count. J Clin Oncol (1993) 0.82
Cytogenetic mapping of the duplicated segment of chromosome 12 in lymphoproliferative disorders. Nature (1982) 0.82
Significance of the low-density lipoprotein (LDL) receptor pathway for the in vitro accumulation of AD-32 incorporated into LDL in normal and leukemic white blood cells. Cancer Treat Rep (1984) 0.82
Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation. Blood (1987) 0.82
Graft-versus-leukaemia activity associated with cytomegalovirus antibody positive bone marrow donors in acute myeloid leukaemia. Lancet (1987) 0.82